Identification | Back Directory | [Name]
FMOC-D-GLA(OTBU)2-OH | [CAS]
111662-65-8 | [Synonyms]
Fmoc-D-Gla(OtBu)?OH FMOC-D-GLA(OTBU)2-OH FMoc-g-carboxy-D-Glu(OtBu)2-OH Fmoc-γ-carboxy-D-Glu(OtBu)2-OH FMOC-D-GLA(OTBU)2-OH USP/EP/BP FMOC-GAMMA-CARBOXY-D-GLU(OTBU)2-OH FMOC-GAMMA-CARBOXY-D-GLUTAMIC ACID(OTBU)2-OH FMOC-D-4-CARBOXYGLUTAMIC ACID DI-TERT BUTYLESTER FMOC-D-4-CARBOXYLGLUTAMIC ACID DI-TERT-BUTYL ESTER Fmoc-γ-carboxy γ-(di-tert-butyl ester)-D-glutamic acid Fmoc-γ-carboxy γ-(di-tert-butyl ester)-D-glutamic acid98+% FMOC-GAMMA-CARBOXY-GAMMA-(DI-T-BUTYL ESTER)-D-GLUTAMIC ACID FMOC-GAMMA-CARBOXY-D-GLUTAMIC ACID GAMMA,GAMMA-DI-T-BUTYL ESTER Fmoc-gamma-carboxy-D-glutamic acid gamma,gamma-di-t-butyl ester quinine (R)-FMoc-2-aMino-4-tert-butoxycarbonyl-pentanedioic acid-5-tert-butyl ester N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)--CARBOXY-L-GLUTAMIC-ACID--DI-T-BUTYL ESTER N-(9-Fluorenylmethyloxycarbonyl)-gamma-carboxy-D-glutamic-acid gamma-di-tert-butyl ester N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-GAMMA-CARBOXY-D-GLUTAMIC-ACID-GAMMA-DI-T-BUTYL ESTER N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-GAMMA-CARBOXY-D-GLUTAMIC-ACID-GAMMA-DI-TERT-BUTYL ESTER (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-4-(tert-butoxycarbonyl)-5-oxopentanoic acid (2R)-5-(tert-butoxy)-4-[(tert-butoxy)carbonyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid 1,1,3-Propanetricarboxylic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, 1,1-bis(1,1-dimethylethyl) ester, (3R)- (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoicaci (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoic acid | [Molecular Formula]
C29H35NO8 | [MDL Number]
MFCD00672341 | [MOL File]
111662-65-8.mol | [Molecular Weight]
525.59 |
Hazard Information | Back Directory | [Uses]
Fmoc-D-Gla(OtBu)2-OH is a protected form of carboxyglutamic acid used in the synthetic preparation of peptides and peptide fragments, such as cyclic RGD pentapeptides. |
|
|